Apocurae SRL
The score of Apocurae shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -61 % Total assets -23 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apocurae's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 30,646 € | ||||
| Equity | 55,177 € | ||||
| Cash | 91,002 € | ||||
| EBITDA | 52,928 € | ||||
| Total assets | 124,948 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 25 Dec 2025
- Year ended 30 Jun 2024filed on 05 Jan 2025
- Year ended 30 Jun 2023filed on 16 Dec 2023
- Year ended 30 Jun 2022filed on 27 Dec 2022
- Year ended 30 Jun 2021filed on 28 Dec 2021
Apocurae's financial analysis
- Solvency44.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apocurae
Apocurae's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0744.938.818
- VAT number
- BE0744938818
- Peppol
- Registered · 0208:0744938818 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Mar 2020
- Registered office
- 8610 Kortemark
- Latest accounts
- 2025 · filed on 25 Dec 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apocurae (SRL) has been based in Kortemark since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 30,646 € and equity of 55,177 €; its revenue is not published. Its solvency stands at 44.2%, below the median of its sector (44.2%).
Companies similar to Apocurae
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Karbon Plus Retail sale of pharmaceutical products Diksmuide · balance sheet 127,790 €
- BSB Pharma Retail sale of pharmaceutical products Berchem-Sainte-Agathe · balance sheet 118,927 €
- Sarina Janssens Farma Retail sale of pharmaceutical products Bierbeek · balance sheet 136,654 €
- Curasan Retail sale of pharmaceutical products Zwalm · balance sheet 103,974 €
- Panax Retail sale of pharmaceutical products Wemmel · balance sheet 99,320 €
- Kato VAN Vooren Retail sale of pharmaceutical products Dendermonde · balance sheet 88,886 €
- VAN Aelst Leonie Retail sale of pharmaceutical products Beernem · balance sheet 86,688 €
Frequently asked questions about Apocurae
What is the revenue of Apocurae?
Apocurae files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apocurae?
In Belgium, the VAT number is the company number prefixed with BE: BE0744938818 for Apocurae, if the company is VAT-registered. Its company number (CBE) is 0744.938.818.
Where is the registered office of Apocurae?
According to the CBE register, the registered office of Apocurae is in 8610 Kortemark.
What is the equity of Apocurae?
At the close of the 2025 financial year, the equity of Apocurae amounts to 55,177 €, a solvency of 44.2% of total assets.
Who manages Apocurae?
The register lists 1 active mandates at Apocurae. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apocurae
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →